Accelagen Revenue and Competitors

USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Accelagen's estimated annual revenue is currently $775k per year.(i)
  • Accelagen's estimated revenue per employee is $155,000

Employee Data

  • Accelagen has 5 Employees.(i)
  • Accelagen grew their employee count by -17% last year.

Accelagen's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$10.1M655%N/AN/A
#10
$16.1M1049%N/AN/A
Add Company

What Is Accelagen?

Accelagen is a fast growing Gene-to-Protein company. Accelagen’s gene-to-protein platform integrates the latest technologies of Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems, providing superior protein quality and accelerating the processes from gene to protein.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M5-17%$76.7M
#2
$0.7M5N/AN/A
#3
$0.3M5N/AN/A
#4
$0.5M5N/AN/A
#5
$0.5M5N/AN/A